Cargando…
How we treat glioblastoma
Glioblastoma is an intrinsic brain tumour thought to arise from neuroglial progenitor cells. Its incidence increases steadily with age. Males are moderately more often affected. Genetic predisposition and exposure to irradiation in childhood are the only established risk factors which, however, acco...
Autores principales: | Weller, Michael, Le Rhun, Emilie, Preusser, Matthias, Tonn, Jörg-Christian, Roth, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586206/ https://www.ncbi.nlm.nih.gov/pubmed/31297242 http://dx.doi.org/10.1136/esmoopen-2019-000520 |
Ejemplares similares
-
How we treat patients with leptomeningeal metastases
por: Le Rhun, Emilie, et al.
Publicado: (2019) -
Venous thromboembolic events in glioblastoma patients: An epidemiological study
por: Eisele, Amanda, et al.
Publicado: (2022) -
A New Landscape for Systemic Pharmacotherapy of Recurrent Glioblastoma?
por: Lombardi, Giuseppe, et al.
Publicado: (2020) -
Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma
por: Seystahl, Katharina, et al.
Publicado: (2022) -
Sex-specific aspects of epidemiology, molecular genetics and outcome: primary brain tumours
por: Le Rhun, Emilie, et al.
Publicado: (2020)